PLASOMA Ultimate Safety & Efficacy Study

计划入组 101 人 · 首次发布于 2021 年 4 月 2 日

PLASOMA Efficacy & Technology Health (PETH) Study

计划入组 46 人 · 首次发布于 2021 年 6 月 10 日

High-Titer Neutralizing Plasma for West Nile Fever in Hospitalized Patients

计划入组 37 人 · 首次发布于 2025 年 7 月 30 日

LC-Plasma

rhu-plasma gelsolin

Platelet-rich Plasma

Biopharma Plasma LLC

Octapharma Plasma, Inc.

United States

THE PLASMA SOURCE

United States

Venture Medical Leads €6 Million Investment in Cold Plasma Wound Therapy Developer Plasmacure

Kamada Receives FDA Approval for Houston Plasma Collection Center, Expanding Specialty Plasma Operations

Kamada Secures FDA Approval for San Antonio Plasma Collection Center, Expanding Specialty Plasma Production Capacity